washington  reuters    maryland lawmakers have passed a first in the nation measure that lets the state attorney general sue generic drug makers that sharply raise prices in a move aimed at fighting what legislators call  price gouging   the bill overwhelmingly was approved by the democratic controlled legislature on monday and hailed by maryland attorney general brian frosh as a way to check sharply higher prices for crucial generic drugs  the maryland measure comes as concerns about rising u s  drug costs have been building for years  for example the  decision by turing pharmaceuticals to increase the cost of a life saving  anti infection drug by   percent sparked widespread outrage  the legislation takes aim at a generic drug market that makes up  percent of u s  pharmaceutical sales and totaled   billion in   according to frosh s office   the market seems to bear it and so some of these manufacturers are charging as much as they possibly can   frosh said in a telephone interview on tuesday  governor larry hogan  a republican  has not said whether he would sign the legislation  his representatives did not respond to requests for comment  the bill allows maryland s state authority on medicaid  a federal healthcare program for the poor  to let the attorney general s office know when it sees patients being charged an  unconscionable increase  for essential generic drugs  the attorney general could then seek an explanation from the manufacturer and sue to protect consumers  with a fine of up to    for each violation  a judge could order the company to reverse its price increase  generics are pharmaceuticals that are equivalent to a brand name drug  they usually are available after patent protections for the original maker run out  the bill did not touch on branded prescription drugs new to the market since their manufacturers have development and patent costs they are entitled to recoup  frosh said   maryland is the first state to pass a measure to combat excessive price increases  according to the national conference of state legislatures  massachusetts  new york  rhode island and tennessee have similar legislation pending  the conference said  the legislation would have a  chilling effect  on the generic market in maryland  said chester davis jr   president of the association for accessible medicines  which represents generic drug makers   use of generic drugs had saved maryland    billion in   he said   to focus on the side of the ecosystem that is actually driving the savings and not the costs definitely seems counterintuitive to us   he said  